Abstract
Fifty-four consecutive patients were treated with transperineal ultrasound-guided 125I seed implantation for Stage B adenocarcinoma of the prostate by a single team. The planned dosimetry was 16,000 rads. The tabulated results indicate an excellent response to interstitial radiation with remarkably few complications and side effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
